SCHEMBL13637206

SCHEMBL13637206

O=C(O)Cc1ccc(OCCCOc2cnc(Cl)cc2-n2nc3ccccc3n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 9/20 0.45
LTB4R2 Q9NPC1 7/20 0.45
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PPARG P37231 2/20 0.41
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
POLB P06746 1/20 0.39
TBXAS1 P24557 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HRH1 P35367 1/20 0.38
PLA2G4B P0C869 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13441819 0.90 KDM4E (0.50) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL3576162 0.87 LTB4R (0.48) LTB4RLTB4R2KDM4EALDH1A1HPGD
SCHEMBL13407823 0.84 NPC1 (0.60) LTB4RLTB4R2KDM4EALDH1A1HPGD
SCHEMBL3587335 0.83 KDM4E (0.46) LTB4RLTB4R2KDM4EALDH1A1HPGD
SCHEMBL13637150 0.83 HPGD (0.44) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL3586956 0.82 KDM4E (0.44) LTB4RLTB4R2KDM4EALDH1A1HPGD
SCHEMBL3577071 0.82 LTB4R (0.50) LTB4RLTB4R2KDM4EALDH1A1HPGD
SCHEMBL13637204 0.82 LTB4R (0.47) LTB4RLTB4R2KDM4EALDH1A1HPGD
SCHEMBL13637202 0.82 LTB4R (0.41) LTB4RLTB4R2KDM4EALDH1A1HPGD
SCHEMBL13442151 0.80 KDM4E (0.42) LTB4RLTB4R2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 US disclosed